Stereotaxis (STXS) Change in Accured Expenses (2010 - 2026)
Stereotaxis' (STXS) quarterly Change in Accured Expenses came in at -$587000.0 in Q1 2026, down 11840.0% year-on-year from N/an in Q1 2025, and down 453.77% on a QoQ basis from -$106000.0 in Q4 2025.
Stereotaxis (STXS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Change in Accured Expenses data on file, last reported at -$587000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 11840.0% year-over-year to -$587000.0 in Q1 2026; TTM through Mar 2026 was -$605000.0, a 264.46% decrease from a year earlier, with the FY2025 full-year figure at -$13000.0, down 161.9% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$587000.0, down from -$106000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for STXS reached as high as $1.2 million in Q2 2023 and fell as low as -$1.5 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$67500.0 across 5 years, with a median of -$9500.0 in 2022.
- Across the five-year window, Change in Accured Expenses soared 19000.0% in 2023 and sank 11840.0% in 2026, its largest moves.
- Year by year, Change in Accured Expenses stood at -$148000.0 in 2022, then sank by 120.27% to -$326000.0 in 2023, then soared by 102.76% to $9000.0 in 2024, then sank by 1277.78% to -$106000.0 in 2025, then sank by 453.77% to -$587000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$587000.0 in Q1 2026, -$106000.0 in Q4 2025, and $238000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.59 Bn | 121.37 Bn | 1.96 Bn | -260.40 Mn |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.93 Bn | 31.27 Bn | 1.53 Bn | - |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 29.39 Bn | 27.73 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 23.40 Bn | 22.97 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.07 Bn | 13.51 Bn | 1.10 Bn | -151.00 Mn |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Stereotaxis | 132.02 Mn | 117.40 Mn | 3.79 Mn | -587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -587,000.00 |
| Mar 31, 2026 | -587,000.00 |
| Dec 31, 2025 | -106,000.00 |
| Dec 31, 2025 | -106,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | -466,000.00 |
| Jun 30, 2024 | -466,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Dec 31, 2023 | -326,000.00 |
| Dec 31, 2023 | -326,000.00 |